ANNA logo
President's Message

.

KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations – 2006 Updates
by ANNA President JoAnne Gilmore

The 2006 Hemodialysis (HD) Adequacy, Peritoneal Dialysis (PD) Adequacy, and Vascular Access KDOQI updates were published recently (NKF, 2006). These new documents have been divided into three major areas, which are discussed below.

    Overview of Sections
    The first section consists of guideline statements that are evidence based. The second section is a new section that consists of opinion-based statements that are called “clinical practice recommendations.” The clinical practice recommendations are opinion based and are based on the expert consensus of the Work Group members. The intention of the Work Group members was that the guideline statements in Section 1 be considered for clinical performance measures because they are supported through evidence-based practice. Because the clinical practice recommendations are opinion based, they should not be considered to have sufficient evidence to support the development of clinical performance measures.

    The third section consists of research recommendations for these guidelines and clinical practice recommendations. The Work Group members decided to combine all research recommendations for the guidelines into one major section and have ranked these recommendations into three categories: (a) critical importance, (b) high importance, and (c) moderate importance. The Work Group members presented these research recommendations to provide a guidepost for funding agencies and investigators to target research efforts in areas that will provide important information to benefit patient outcomes. As we all know, implementation is a critical component of the KDOQI process. With that in mind, the National Kidney Foundation’s Kidney Learning System (KLS) is developing implementation tools for these guidelines.

    Guideline 1: Initiation of Dialysis. Guideline 1 is titled “Initiation of Dialysis” and states that patients who reach CKD Stage 4 (estimated GFR less than 30 mL/min/1.73 m2) should receive timely education about kidney failure and options for its treatment, including kidney transplantation, PD, HD in the home or in-center, and conservative treatment. Patients’ family members and caregivers also should be educated about treatment choices for kidney failure. As I read this guideline, I think of living in an ideal world where our patients and their families could receive education prior to reaching stage 4. Am I dreaming? Maybe, probably, but isn’t it nice to dream?
    The rationale for early education should ring a bell for all nephrology nurses, and certainly our APNs and CKD nurses. It states that timely education will:
    • allow patients and families time to assimilate the information and weigh treatment options,
    • allow evaluation of recipients and donors for preemptive kidney transplantation,
    • allow staff time to train patients who choose home dialysis,
    • ensure that uremic cognitive impairment does not cloud decisions, and
    • maximize the probability of orderly and planned treatment initiation using a permanent access.
    Guideline 2: PD Adequacy. The PD Adequacy guidelines represent a complete revision of the original guidelines. The guidelines are primarily for patients on continuous ambulatory PD (CAPD) and are organized into clinical practice guidelines and clinical practice recommendations. The guidelines are based on available evidence if it exists. Per the authors, much more evidence is needed; therefore they are strongly discouraging oversight bodies from using the clinical practice guidelines for clinical performance measurements. Of note, in the original PD guidelines, a target goal for solute clearance was recommended. In the updated guidelines, a minimum dose is recommended. But again, education beginning in CKD Stage 4 is emphasized.

    Guideline 3: Vascular Access. And finally, the Achilles Heel for many of our patients, vascular access. The guidelines stress the goal of early identification of patients with progressive kidney disease and the identification and protection of potential fistula construction sites – particularly sites using the cephalic vein – by members of the health care team and patients. There are explicit guidelines regarding which tests to use to evaluate a given access type and when and how to intervene to reduce thrombosis and underdialysis. The Work Group believes these guidelines are reasonable, appropriate, and achievable and that attainment of the goals will require the concerted efforts of patients and the entire health care team.

    Summary
    In scanning through the KDOQI guidelines for this article, I applaud the Work Group members as there is an emphasis placed on timely education of the patient, their family members, close friends, and/or primary care providers for both HD and PD. We have all seen in our practice setting, how critical education is for our patients. Studies have shown that timely patient education as CKD advances can both improve outcomes and reduce cost. These guidelines certainly emphasize the importance of advocating for education of patients with CKD. We know that we as nephrology nurses are crucial for educating the patient with CKD, the patient with ESRD, family members, and caregivers and for re-enforcing their education.

    JoAnne Gilmore, BSN, RN, CNN
    ANNA President

    References
    National Kidney Foundation (NKF). (2006). KDOQI clinical practice guidelines and clinical practice recommendations for 2006. Updates: Hemodialysis adequacy, peritoneal dialysis adequacy and vascular access. American Journal of Kidney Disease, 48(Suppl 1), S1-S322.
     
     

    Copyright 2006, American Nephrology Nurses' Association. Anthony J. Jannetti, Inc., publisher. An iNurse Web site.